United States HR 6832: To amend the Federal Food, Drug, and Cosmetic Act and the Defense Production Act of 1950 to prohibit the Federal Government from limiting State access to key therapies, such as monoclonal antibodies, and from prioritizing Federal contracts over State contracts relating to purchasing supplies to combat the COVID-19 pandemic.

Status: Referred to the Subcommittee on Health. (as of 2022-02-28)

State: United States · Session: 117 · Bill: HR 6832

Sponsors: Michael Cloud, Andy Biggs, Byron Donalds, Daniel Webster, Mary E. Miller, Mo Brooks, Thomas P. Tiffany

View United States HR 6832 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.